Understanding the problems in pharmaceutical procurement with special reference to active pharmaceutical ingredients and excipients

被引:0
|
作者
Zauwad Alam
Sukhbir Kaur
Pawan Kumar Porwal
机构
[1] ISF College of Pharmacy,Incompatibility Study Division & Analytical Laboratory (ISFAL), Department of Quality Assurance
[2] Amity University Madhya Pradesh,Amity Institute of Pharmacy (AIP)
来源
Accreditation and Quality Assurance | 2018年 / 23卷
关键词
Pharmaceutical procurement; Active pharmaceutical ingredient; Regulatory requirements; User requirement specifications; Vendor certification procedure;
D O I
暂无
中图分类号
学科分类号
摘要
Procurement of raw materials, key intermediates and excipients for the preparation of finished pharmaceutical preparation is considered to be complex process which involve multiple channels and require skilled personnel and proper validation. This review attempts, in relatively brief compass to provide an account of the problems that arise while procurement of active pharmaceutical ingredient (API) and excipients in pharmaceutical industry. This review has been structured with specified as well as generalized problems raised up during procurement of API and other material in pharmaceutical industry. Lack of proper regulatory requirements and unbiased market information with the absence of a comprehensive procurement policy is the major factor which creates complications while procurement. Besides these, lack of properly designed user requirement specifications (URS) which ultimately affect quality and delivery of quoted material. An 8-Question-based approach has been proposed to design URS, other approaches for material procurement and supplier qualification have been discussed, and a vendor certification procedure is presented.
引用
收藏
页码:319 / 328
页数:9
相关论文
共 50 条
  • [21] Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients
    LaPorte, Thomas L.
    Wang, Chenchi
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (06) : 738 - 745
  • [22] Comparison of near-infrared spectroscopic methods for the identification of pharmaceutical excipients and active drug ingredients
    Palmer, K. E.
    Jee, R. D.
    Kraunsoe, J. A. E.
    Bellchambers, M.
    Moffat, A. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S80 - S80
  • [23] Comparison of near-infrared spectroscopic methods for the identification of pharmaceutical excipients and active drug ingredients
    Palmer, K. E.
    Jee, R. D.
    Kraunsoe, J. A. E.
    Bellchambers, M.
    Moffat, A. C.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S10 - S11
  • [24] The influence of polymeric excipients on desupersaturation profiles of active pharmaceutical ingredients. 1: Polyethylene glycol
    Schneider, Raj
    Taspinar, Luetfi
    Ji, Yuanhui
    Sadowski, Gabriele
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 582
  • [25] Manufacturing peptides as active pharmaceutical ingredients
    Zompra, Aikaterini A.
    Galanis, Athanassios S.
    Werbitzky, Oleg
    Albericio, Fernando
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 361 - 377
  • [26] The revival of cyclodextrins as active pharmaceutical ingredients
    Kfoury, Miriana
    Lichtfouse, Eric
    Fourmentin, Sophie
    ENVIRONMENTAL CHEMISTRY LETTERS, 2025, 23 (01) : 1 - 6
  • [27] Ionic Liquids as Active Pharmaceutical Ingredients
    Ferraz, Ricardo
    Branco, Luis C.
    Prudencio, Cristina
    Noronha, Joao Paulo
    Petrovski, Zeljko
    CHEMMEDCHEM, 2011, 6 (06) : 975 - 985
  • [28] Precision active pharmaceutical ingredients are the goal
    Miller, Andrew D.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (11) : 1209 - 1238
  • [29] Active pharmaceutical ingredients are big business
    Stoker, A
    TCE, 2002, (732): : 38 - 39
  • [30] Active pharmaceutical ingredients and osteonecrosis of the jaw
    Orvosi Osztaly
    ORVOSI HETILAP, 2020, 161 (51) : 2176 - 2176